Related references
Note: Only part of the references are listed.Scaling-up HCV prevention and treatment interventions in rural United Statesmodel projections for tackling an increasing epidemic
Hannah Fraser et al.
ADDICTION (2018)
Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses
Yvan J-F Hutin et al.
GUT (2017)
Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network
A. Wranke et al.
JOURNAL OF HEPATOLOGY (2017)
Access to medicines: lessons from the HIV response
Stefano Vella et al.
Lancet HIV (2017)
Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
Rakesh Aggarwal et al.
PLOS ONE (2017)
Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan
Adam Trickey et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus
M. H. Hyun et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia
Yusuke Shimakawa et al.
GUT (2016)
A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants
Hari Shankar et al.
CLINICAL INFECTIOUS DISEASES (2016)
Public health and international drug policy
Joanne Csete et al.
LANCET (2016)
Requirements for global elimination of hepatitis B: a modelling study
Shevanthi Nayagam et al.
LANCET INFECTIOUS DISEASES (2016)
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
Louisa Degenhardt et al.
LANCET INFECTIOUS DISEASES (2016)
Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014
Eric Wiesen et al.
VACCINE (2016)
Barriers to timely administration of birth dose vaccines in The Gambia, West Africa
Reiko Miyahara et al.
VACCINE (2016)
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
Maud Lemoine et al.
LANCET GLOBAL HEALTH (2016)
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China
Mehlika Toy et al.
PLOS ONE (2015)
Evolution of the Global Use of Unsafe Medical Injections, 2000-2010
Jacques Pepin et al.
PLOS ONE (2013)
Unnecessary injecting of medicines is still a major public health challenge globally
C. Gore et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
Bradley M. Mathers et al.
LANCET (2010)
The blood donor in sub-Saharan Africa: a review
C. T. Tagny et al.
TRANSFUSION MEDICINE (2010)
Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications
Manju Rani et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2009)
Delta hepatitis: an update
P Farci
JOURNAL OF HEPATOLOGY (2003)
Share Paper
